Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus

Overview of attention for article published in Frontiers in endocrinology, September 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy: 1 policy source

twitter: 7 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 63 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Metformin Extended Release versus Immediate Release for Type 2 Diabetes

Cited by Canadian Agency for Drugs and Technologies in Health on 31 May 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.